Treatment of Migraine Attacks with Sumatriptan: The Subcutaneous Sumatriptan International Study Group

New England Journal of Medicine

Volumn 325, Issue 5, 1991, Pages 316-321

  Ferrari, Michel D ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SUMATRIPTAN;

ADULT; ARTICLE; CONTROLLED STUDY; DROWSINESS; FEMALE; FLUSHING; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PARESTHESIA; PRIORITY JOURNAL; SIDE EFFECT; SUBCUTANEOUS DRUG ADMINISTRATION; VERTIGO;

ADOLESCENT; ADULT; AGED; CONSUMER SATISFACTION; DOUBLE-BLIND METHOD; DRUG TOLERANCE; FEMALE; HUMAN; INDOLES; MALE; MIDDLE AGE; MIGRAINE; RECEPTORS, SEROTONIN; RECURRENCE; SAFETY; SULFONAMIDES; SUMATRIPTAN; VASOCONSTRICTOR AGENTS;

EID: 0025913813     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199108013250504     Document Type: Article

References (26)

1. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8: Suppl 7: 1–96.
2. Ziegler DK. Epidemiology of migraine. In: Vinken PJ, Bruyn GW, Klawans HL, Rose FC, eds. Headache. Vol. 48 of Handbook of clinical neurology. Amsterdam: Elsevier Science, 1986:13–22.
3. Cook NR, Evans DA, Funkenstein HH. Correlates of headache in a population-based cohort of elderly. Arch Neurol 1989; 46: 1338–44.
4. Linet MS, Stewart WF, Celentano DD, Ziegler D, Sprecher M. An epidemiological study of headache among adolescents and young adults. JAMA 1989; 261: 2211–6.
5. Linet MS, Stewart WF. The epidemiology of migraine headache. In: Blau JN, ed. Migraine: clinical, therapeutic, conceptual and research aspects. London: Chapman & Hall, 1987:451–77.
6. Peatfield RC, Fozard JR, Rose FC. Drug treatment of migraine. In: Vinken PJ, Bruyn GW, Rose FC, eds. Headache. Vol. 48 of Handbook of clinical neurology. Amsterdam: Elsevier Science, 1986:173–216.
7. Perrin VL. Clinical pharmacokinetics of ergotamine in migraine and cluster headache. Clin Pharmacokinet 1985; 10: 334–52.
8. Thrush D. Does ergotamine work for migraine? In: Warlow C, Garfield J, eds. Dilemmas in the management of the neurological patient. Edinburgh, Scotland: Churchill Livingstone, 1984:106–14.
9. Lance JW, Lambert GA, Goadsby PJ, Zagami AS. 5-Hydroxytryptamine and its putative aetiological involvement in migraine. Cephalalgia 1989; 9: Suppl 9: 7–13.
10. Ferrari MD, Odink J, Tapparelli C, Van Kempen GMJ, Pennings EJM, Bruyn GW. Serotonin metabolism in migraine. Neurology 1989; 39: 1239–42.
11. Saxena PR, Ferrari MD. 5–HT1-like receptor agonists and the pathophysiology of migraine. Trends Pharmacol Sci 1989; 10: 200–4.
12. Moskowitz MA, Henrikson BM, Markowitz S, Saito K. Intra- and extracraniovascular nociceptive mechanisms and the pathogenesis of headpain. In: Olesen J, Edvinsson L, eds. Basic mechanism of headache. Amsterdam: Elsevier Science, 1988:429–37.
13. Humphrey PPA, Feniuk W, Perren MJ, Conner HE, Oxford AW. The pharmacology of the novel 5–HT1-like receptor agonist, GR43175. Cephalalgia 1989; 9: Suppl 9: 23–33.
14. Perren MJ, Feniuk W, Humphrey PPA. The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia 1989; 9: Suppl 9: 41–6.
15. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990; 99: 202–6.
16. Perrin VL, Farkkila M, Goasguen J, Docnicke A, Brand J, Tfelt-Hansen P. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia 1989; 9: Suppl 9: 63–72.
17. Tfelt-Hansen P, Brand J, Dano P, et al. Early clinical experience with subcutaneous GR43175 in acute migraine: an overview. Cephalalgia 1989; 9: Suppl 9: 73–7.
18. Ferrari M, Bayliss EM, Ludlow S, Pilgrim AJ. Subcutaneous GR43175 in the treatment of acute migraine: an international study. Cephalalgia 1989; 9: Suppl 10: 348.
19. Byer J, Gutterman DL, Plachetka JR, Bhattacharyya H. Dose response study for subcutaneous GR43175 in the treatment of acute migraine. Cephalalgia 1989; 9: Suppl 10: 349–50.
20. Doenicke A, Brand J, Perrin VL. Possible benefit of GR43175, a novel 5–HT1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1988; 1: 1309–11.
21. Lance JW, Anthony M. Some clinical aspects of migraine: a prospective survey of 500 patients. Arch Neurol 1966; 15: 356–61.
22. Adult migraine: the patient observed. In: Blau JN, ed. Migraine: clinical, therapeutic, conceptual and research aspects. London: Chapman & Hall, 1987:3–30.
23. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986; 26: 168–71.
24. Leon-Sotomayor LA. Cardiac migraine — a report of twelve cases. Angiology 1974; 25: 161–71.
25. Perera GA. Paroxysmal arrhythmias and migraine. JAMA 1971; 215: 488.
26. Baborier D, Blanc PL, Berthou JD. Association migraine et troubles du rhythme cardiaque. J Med Strasbourg 1985; 16: 589. abstract.